Altered glomerular extracellular matrix synthesis in experimental membranous nephropathy.
Chronic progressive membranous nephropathy (MN) in humans is characterized by thickening of the glomerular basement membrane (GBM) with formation of spikes which contain laminin and other extracellular matrix (ECM) proteins. We have utilized two models of MN in the rat (active and passive Heymann nephritis, AICN, PHN) to define the sequential changes in composition of GBM as they relate to changes in glomerular gene expression for ECM components, altered permeability and morphological changes. Renal biopsies obtained during the course of AICN and PHN were immunostained for various ECM proteins and total glomerular RNA was hybridized with cDNA probes specific for laminin B2-chain, s-laminin, and types I and IV collagen. In addition, the ability of anti-glomerular epithelial cell (GEC) antibody and complement on rat GEC in culture to induce laminin release or laminin and s-laminin mRNA expression was determined. The results demonstrate that at weeks 12, 16, and 20 of AICN, immunostaining for laminin, s-laminin, fibronectin, entactin, and heparan sulfate proteoglycan increased in the GBM in a spike-like pattern. Concomitantly, glomerular mRNA levels of laminin B2-chain and of s-laminin increased. Type IV collagen protein and gene expression remained unchanged or decreased. No glomerular immunostaining for type I collagen occurred during AICN despite increased expression of mRNA for this collagen type. In contrast to AICN, in PHN no pronounced changes of the glomerular ECM occurred, except for transient expression of type I collagen mRNA in whole glomerular RNA and type I collagen protein the GEC cytoplasm. Stimulation of GEC in culture with anti-GEC antibody and complement also failed to induce transcription of laminin or s-laminin mRNA or the release of laminin protein. These findings suggest that the polyantigenic expansion of GBM which occurs in chronic experimental MN may be stimulated by factors different from the C5b-9 mediated processes that cause the initial proteinuria.
Floege
J
J
Department of Medicine, University of Washington, Seattle.
Johnson
R J
RJ
Gordon
K
K
Yoshimura
A
A
Campbell
C
C
Iruela-Arispe
L
L
Alpers
C E
CE
Couser
W G
WG
D000818:Animals; D000906:Antibodies / Q000276:immunology; D003165:Complement System Proteins / Q000276:immunology; D005109:Extracellular Matrix / Q000378:metabolism*; D016326:Extracellular Matrix Proteins / Q000235:genetics / Q000378:metabolism; D015870:Gene Expression; D005921:Glomerulonephritis / Q000378:metabolism; D015433:Glomerulonephritis, Membranous / Q000235:genetics / Q000276:immunology / Q000378:metabolism*; D007158:Immunologic Techniques; D007678:Kidney Glomerulus / Q000378:metabolism*; D007797:Laminin / Q000235:genetics / Q000378:metabolism; D012333:RNA, Messenger / Q000378:metabolism; D051381:Rats; D011917:Rats, Inbred Lew; D012016:Reference Values; D013194:Staining and Labeling
D000906:Antibodies; D016326:Extracellular Matrix Proteins; D007797:Laminin; D012333:RNA, Messenger; D003165:Complement System Proteins